RELATING TO CONTROLLED SUBSTANCES.
Summary
Requires drug manufacturers to establish and implement drug take-back programs or join drug take-back organizations for purposes of collecting and disposing of various types of prescription and nonprescription drugs. Specifies requirements for the department of public safety, covered manufacturers, drug take-back program operators, authorized collectors, and other entities who establish or participate in drug take-back programs.
Bill status
in committee
1 of 4 stages cleared
Introduction
Jan 2021
Committee Review
Floor Vote
Governor
Introduced Jan 22, 2021
Last action Jan 27, 2021
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
1
Jan 27, 2021
Committee
Referred to HHH, CPC, FIN, referral sheet 1
lower
Jan 25, 2021
Introduced
Introduced and Pass First Reading.
lower
Jan 22, 2021
Introduced
Pending introduction.
lower
11 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Adrian K. Tam
DDemocratic
P
Amy Perruso
DDemocratic
P
Angus McKelvey
DDemocratic
P
David Tarnas
DDemocratic
P
JK
Jeanné Kapela
DDemocratic
P
Lauren Matsumoto
RRepublican
P
MS
Matthew S. LoPresti
DDemocratic
P
May Mizuno
DDemocratic
P
Nicole Lowen
DDemocratic
P
Scot Matayoshi
DDemocratic
P
TW
Tina Wildberger
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 386
Scope: HI
Hi! I can help you understand HB 386. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline